G. V. Buren

A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).

H. Heslop, W. Fisher, C. Ramos, 2020 .

MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients

Mohamed O. Othman, F. Carrier, Young-Il Kim, 2023, Cancers.

Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer

G. V. Buren, Zachary Gao, Joseph Azar, 2023, Frontiers in oncology.